BNP Paribas Financial Markets’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$46.4K Buy
2014
Q4
Sell
2014
Q3
$88.7K Buy
2014
Q2
$6.71K Buy
2014
Q1
Sell
2013
Q4
$16.1K Sell
2013
Q3
$299K Sell
2013
Q2
$267K Buy